X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

PhRMA submits comments on FDA’s proposed rule on drug importation

By Nicole Longo  |    March 10, 2020
Yesterday, PhRMA submitted comments in response to the Food and Drug Administration’s proposed rule, “Importation of Prescription Drugs.” As PhRMA President and CEO Stephen J. Ubl stated when the...   Read More

Drug importation: An old idea that is still a bad idea

By Nicole Longo  |    January 28, 2020
2020 may have kicked off a new decade, but policymakers are stuck in the past, focusing on old, dangerous ideas like drug importation. For all the same reasons we’ve discussed before, drug...   Read More

What they’re saying: Safety is top concern for recent drug importation proposal

By Nicole Longo  |    August 8, 2019
Last week, the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) released their “Safe Importation Action Plan,” which would allow importation of...   Read More

ICYMI: Canadian government, stakeholders voice concerns with drug importation proposals

By Tiffany Haverly  |    August 1, 2019
This week, the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration announced their “Safe Importation Action Plan.” While patients are rightfully concerned about...   Read More

PhRMA responds to Florida’s request for information on drug importation

By Tiffany Haverly  |    June 26, 2019
PhRMA remains committed to working with lawmakers to ensure patients can afford and access their medicines, but importation schemes that put patient safety at risk will never be the right approach.   Read More

PhRMA CEO raises concerns with Florida importation proposal, highlights reforms needed to lower costs for patients

By Tiffany Haverly  |    May 8, 2019
PhRMA is committed to working with lawmakers to ensure patients can access and afford their medicines, but importation schemes that put patient safety at risk are the wrong approach. In a recent...   Read More

Look at the facts. Drug importation is dangerous.

By Nicole Longo  |    February 22, 2019
Today, 1 in 10 medicines worldwide and up to 50 percent of drugs consumed in developing nations are counterfeit. Importation proposals would open the U.S. borders to these dangerous and...   Read More

New research shows increasing medication-assisted treatment rates could prevent 6.1 million overdoses and save over 800,000 lives

By Priscilla VanderVeer  |    December 17, 2018
New research released this week highlights the barriers that patients face in accessing medication-assisted treatment (MAT) for opioid use disorder (OUD) and the personal, health and societal...   Read More

Securely dispose of your unwanted medicines on National Take Back Day

By Caitlin Carroll  |    April 28, 2018
Today, the U.S. Drug Enforcement Administration hosts its annual National Prescription Drug Take Back Day. The awareness day helps educate people on the need to properly dispose of expired or...   Read More

The Washington Post retracts PhRMA claim in opioid story

By Holly Campbell  |    October 18, 2017
Earlier this week, The Washington Post falsely claimed that the PhRMA supported the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and spent $40 million advocating for its...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates